Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy. Issue 1 (January 2018)
- Record Type:
- Journal Article
- Title:
- Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy. Issue 1 (January 2018)
- Main Title:
- Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy
- Authors:
- Ou, Dan
Garberis, Ingrid
Adam, Julien
Blanchard, Pierre
Nguyen, France
Levy, Antonin
Casiraghi, Odile
Gorphe, Philippe
Breuskin, Ingrid
Janot, François
Temam, Stephane
Scoazec, Jean-Yves
Deutsch, Eric
Tao, Yungan - Abstract:
- Abstract: Background and purpose: The aim of the present study was to investigate the role of three hypoxia-related biomarkers in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with concurrent chemoradiotherapy (3-weekly cisplatin) or bioradiotherapy (weekly cetuximab). Material and methods: In tumor tissue material from 100 patients with known HPV status, we evaluated the extent of tumor necrosis, the expression level of CA-IX and the microvascular density (MVD) measured as the density of CD34+ vascular structures. The correlations between biomarker expressions and clinicopathological characteristics and treatment outcomes were analyzed. Results: We found a significant correlation of MVD with UICC stage ( p = 0.02) and T classification ( p = 0.05), of CA-IX with UICC stage ( p = 0.03) and N classification ( p = 0.04) and a significant inverse correlation of MVD with CA-IX expression ( r = − 0.22, p = 0.03). Multivariate analysis showed that low MVD combined with high CA IX-expression was a significant independent prognostic factor for worse loco-regional control (HR = 2.6, 95%CI 1.1–5.0, p = 0.02) in the whole population but not in the p16+ subgroup. Patients treated with CRT had a better LRC than those with BRT independent of MVD or CA-IX expression. Conclusions: The combination of MVD and CA-IX expression might give additional prognostic information in HNSCC patients with known HPV status.
- Is Part Of:
- Radiotherapy and oncology. Volume 126:Issue 1(2018)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 126:Issue 1(2018)
- Issue Display:
- Volume 126, Issue 1 (2018)
- Year:
- 2018
- Volume:
- 126
- Issue:
- 1
- Issue Sort Value:
- 2018-0126-0001-0000
- Page Start:
- 116
- Page End:
- 124
- Publication Date:
- 2018-01
- Subjects:
- Head-and-neck squamous cell carcinoma -- CD34 -- CA-IX -- Necrosis -- Human papillomavirus
Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2017.10.007 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11319.xml